Company Hongchang International Co., Ltd

HCIL

US42831T2024

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - OTC Markets Other stock markets 09:31:03 2024-05-06 am EDT			5-day change	1st Jan Change
0.2501 ^USD	+12.35%		+12.35%	-28.30%

Apr. 01	Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 01	Hongchang International Co., Ltd Announces Board Changes	CI

Hongchang International Co Ltd, formerly Heyu Biological Technology Corp, is a holding company mainly engaged in research and development and manufacture a medical product, the Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber (the Chamber). Utilizing submillimeter waves, the Chamber is a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber.

Managers	Title	Age	Since
Zeng Qiang Lin CEO	Chief Executive Officer	28	23-02-16
Wendy Li DFI	Director of Finance/CFO	39	18-04-17
Siong Ang Ban CHM	Chairman	49	18-04-17

Members of the board	Title	Age	Since
Siong Ang Ban CHM	Chairman	49	18-04-17
Jian Xin Gao BRD	Director/Board Member	62	23-08-20
Zeng Qiang Lin CEO	Chief Executive Officer	28	23-02-16
Zhen Zhu Lin BRD	Director/Board Member	32	23-08-20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	518,831,367	12,295,756 ( 2.370 %)	0	2.370 %

Name	Equities	%	Valuation
Zeng Qiang Lin 68.10 %	353,322,843	68.10 %	230 M $
Zhen Zhu Lin 12.00 %	62,259,532	12.00 %	40 M $
Ban Siong Ang 10.80 %	56,011,747	10.80 %	36 M $
Pheng Ang Hooi 6.735 %	34,941,489	6.735 %	23 M $

Hongchang International Co., Ltd.

Block 20, Yuanhong Investment Zone Donggao Village

350300, Fuzhou

address Hongchang International Co., Ltd(HCIL)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
HONGCHANG INTERNATIONAL CO., LTD	-28.30%	130M
ELI LILLY AND COMPANY	+33.43%	690B
NOVO NORDISK A/S	+26.43%	546B
JOHNSON & JOHNSON	-5.12%	358B
MERCK & CO., INC.	+19.59%	323B
ABBVIE INC.	+4.89%	287B
ASTRAZENECA PLC	+14.32%	235B
NOVARTIS AG	+5.79%	199B
ROCHE HOLDING AG	-9.49%	195B
AMGEN INC.	+4.26%	161B

Other Pharmaceuticals